BusinessFibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)By Nasdaq OMXJan 30, 2018, 1:02 PM UTC
BusinessMadrigal Announces Acceptance of MGL-3196 Abstract for a Main Plenary Presentation at The International Liver Congress™ 2018By Nasdaq OMXJan 30, 2018, 12:00 PM UTC
BusinessPressure BioSciences, Inc. CEO, Ric Schumacher, Rejoins “Stock Day”, Very Optimistic About His Company’s Growth and Success in 2018 and BeyondBy Nasdaq OMXJan 29, 2018, 4:09 PM UTC
BusinessSynthego Launches Powerful CRISPR Analysis Software To Make World-Class Genome Engineering AccessibleBy Nasdaq OMXJan 29, 2018, 2:04 PM UTC
BusinessNetworkNewsWire Announces Publication on Advancements in Cannabis Industry Biotech TherapyBy Nasdaq OMXJan 26, 2018, 1:30 PM UTC
BusinessBeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Oncology SymposiumBy Nasdaq OMXJan 26, 2018, 1:01 PM UTC
BusinessKraig Biocraft Laboratories Expands Material Performance Testing ProceduresBy Nasdaq OMXJan 25, 2018, 9:58 PM UTC
BusinessHistogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional SharesBy Nasdaq OMXJan 25, 2018, 9:05 PM UTC
